Navigation Links
Antidepressants come in handy for patients on treatment for hepatitis, cancers and multiple sclerosis

The sad part in the treatment of certain cancers, hepatitis and multiple sclerosis with interferon therapy is that while the treatment can extent life, it can seriously spoil its quality. Alpha interferon a drug used to fight these diseases can cause crippling depression.

A new research now shows that the use of an antidepressant before starting the treatment can avoid this problem. Almost 50% of people on chemotherapy with high dose interferon for skin cancer (malignant melanoma), developed severe depression. But when they were given antidepressant Paxil for two weeks before chemotherapy, only 11% developed depression.

Dr. Andrew H. Miller, MD of the department of psychiatry and behavioral science at Emory University School of Medicine in Atlanta, says doctors have assumed for years that depression therapies themselves can induce depression.

The good news is that Paxil and other antidepressants not only help alleviate the depression that could cause people to stop treatment, but also help in other ways. Study participants who took Paxil before undergoing 12 weeks of interferon treatment reported less pain and fewer instances of gastric irritations. They also reported less confusion or memory problems and slightly less fatigue than people who didn’t get the antidepressants
'"/>




Page: 1

Related medicine news :

1. Antidepressants increase gastric bleeding
2. Antidepressants-important role
3. Antidepressants increase gastric bleeding
4. Antidepressants could pose grave implications
5. Antidepressants May Benefit Heart Patients
6. Antidepressants Harmful for Kids
7. Antidepressants For Children: How safe is it ?
8. Antidepressants Late In Pregnancy Harmful to Unborn Baby
9. Antidepressants Could Lead To Abnormal Bleeding
10. Young Patients On Antidepressants Found To Be Associated With Suicidal Tendencies
11. Antidepressants linked to reduced risk of heart attacks
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/24/2017)... , ... March 24, 2017 , ... ... Society (ONS) wanted to create a communications platform that positions them as the ... Elliance and ONS reinvented their online publication as an always-on, always-fresh news, views ...
(Date:3/24/2017)... ... March 24, 2017 , ... Gastro ... their partnership to prep patients for colonoscopy at the HyGIeaCare® Center that is ... Ave., Miami, FL. , The HyGIeaCare® Prep, cleared by the U.S. ...
(Date:3/24/2017)... ... March 24, 2017 , ... “Vintage and Harvest A Cultivation ... and college Bible teacher residing in North Carolina with his wife, Anna Marie. He ... them with six grandchildren. David is also the author of “Shadow and Substance.” , ...
(Date:3/23/2017)... ... 2017 , ... The physicians of KSF Orthopaedic Center PA are proud to ... location is located at 2255 E. Mossy Oaks Rd., Suite 440, Spring, Texas 77389 ... provide patients living in the north Houston area (The Woodlands, Conroe, Magnolia, Kingwood, Humble) ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... The MBI “Hall of Fame” recognizes the ... acts have had a significant impact on the careers of all others involved. ... Inc. was inducted into the MBI’s Hall of Fame. The induction took place during ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... Research and Markets has announced the ... Strategies" report to their offering. ... Pain Management in the ... their physical pain, emphasizing consumer survey analysis, including trends over ... adults who have selected illnesses/conditions strongly associated with physical pain ...
(Date:3/24/2017)... 24, 2017 ShangPharma, a leading ... cost-effective drug development and discovery services, technology, ... industry, announced today the intent for a ... be consolidating the Contract Research Organizations (CRO) ... ChemPartner. These entities include ChemPartner Shanghai, ChemPartner ...
(Date:3/24/2017)... , Mar. 24, 2017 Research and Markets ... Pipeline Analysis, 2016" report to their offering. ... The IPF pipeline is very strong with a ... Merck & Co., Inc., Biogen and Sanofi are involved in the development ... of which one is in Phase III stage, 15 are in Phase ...
Breaking Medicine Technology: